Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jun 2021 for Aditx Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleRowena Albanna
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-36.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Rowena Albanna: trading record in brief
Rowena Albanna, listed as chief executive, appears in our data through filings on Aditxt, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 1 June 2021 and the latest from 4 June 2021.
On the market, this insider has only ever bought: 1 purchase, €1,199 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
The record was last updated on 8 June 2021 with a share grant in Aditxt, Inc. The last insider purchase was made public on 2 June 2021, 1,965 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rowena Albanna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
75,000 shares0Common StockSEC:0001213900-21-031447:0
500 shares@ US$2.93100.0% of flowCommon StockSEC:0001213900-21-030429:0
Canonical exit: 30 Aug 2021 (T+90)
2 of 2 declarations
